Kimberly Manhard

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ACAD

Current role

HRTX

Current role

Board Member

2016-01-01–present

INBX

Current role

Board Member

2024-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President, Drug Development	$545,834	—	$441,456	$235,482	$204,688	$19,647	$1,447,107
2021	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President, Drug Development	$514,937	—	$583,626	$535,147	$205,975	$18,893	$1,858,578
2020	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President,	$519,167	—	$314,400	$1,154,364	$199,976	$8,550	$2,196,457
2019	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President,	$490,136	—	—	$1,815,276	$196,054	$8,400	$2,509,866
2018	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President,	$466,796	—	—	$1,605,220	$350,097	$8,250	$2,430,363

No earnings-call appearances or filed executive changes recorded yet.